期刊文献+

小儿肺炎支原体感染后免疫功能的变化规律及其临床意义 被引量:23

Study on change and clinical significance of immune function in children infected with Mycoplasma pneumoniae
下载PDF
导出
摘要 目的探讨小儿肺炎支原体感染后免疫功能的变化规律及其临床意义。方法选取2008年8月至2013年11月肺炎支原体感染患儿106例作为实验组,选取同期体检健康的小儿106作为对照组,对两组的血清免疫球蛋白(Ig A、Ig M、Ig G)和补体C3、C4红细胞免疫状态(免疫复合物花环率、C3b受体花环率、免疫粘附促进以及抑制因子)、外周血的T淋巴细胞亚群(CD3+、CD8+、CD4+和CD4/CD8)水平进行检测。结果实验组患儿急性期免疫球蛋白、红细胞免疫的水平及外周血的T淋巴细胞亚群均低于对照组,恢复期两组上述差异依然存在,仅差异幅度变小(P<0.05);急性期和恢复期相比,差异也有统计学意义(P<0.05)。结论小儿受到肺炎支原体感染后免疫功能都是处于低下的状态,改善免疫状态,对于改善疾病的状态具有积极的作用。 Objective To investigate the clinical significance and changes of immune function in children infected with Mycoplasma pneu-moniae(M. pneumoniae). Methods From August 2008 to November 2013,106 cases of children with M. pneumoniae infection were selected as experimental group,106 healthy children were as control group. Serum levels of IgA,IgM,IgG,complement C3 and C4 ,red blood cell im-mune status( immune complex rosette,C3b receptor rosette,immune adhesion promoting and inhibiting factors),and peripheral blood T lympho-cyte subsets(CD3 ^+,CD8 ^+,CD4^ + and CD4/CD8)were detected in both groups. Results The immune globulin,red cell immune level and peripheral blood T lymphocyte subsets in the experimental group were lower than those in the control group in both acute phase and recovery phase of the infection( P 〈0. 05),and these differences between the acute phase and recovery phase of the infection were also statistically significant( P 〈0. 05). Conclusion The immune function is inhibited during M. pneumoniae infection and the improvement of immune status may play a positive role in the treatment of the infection.
出处 《临床和实验医学杂志》 2014年第24期2021-2023,共3页 Journal of Clinical and Experimental Medicine
基金 惠州市科学技术局科技项目(2013 Y083)
关键词 小儿 肺炎支原体感染 免疫功能 T淋巴细胞 血清免疫球蛋白 Children Mycoplasma pneumoniae Immune function T lymphocyte Serum immunoglobulin
  • 相关文献

参考文献12

  • 1Hassan J,Irwin F,Dooley S,et al.Mycoplasma pneumoniae infection in a pediatric population:analysis of soluble immune markers as rosk fa- tors for asthma[J].Hun Immunol,2010,69(12):851-855.
  • 2Mamessier E,Botturik,Verloet D,et al.T regulatory Lymphocytes,atopy and asthma:A new concept in three dimensions [J].Revmal Re- spir,2011,22(2):305-311.
  • 3陈斌,李晓春.支原体肺炎患儿外周血淋巴细胞亚群监测及临床意义[J].临床肺科杂志,2010,15(6):871-871. 被引量:18
  • 4Stemach I,Podisadlowicz Borzecka M,et al.Humorl and cellular im- munity in children wity Mycoplasma pneumoniae infection:a 12 year prospective study[J].Clin Diagn Lab Tmmunol,2012,12(10):1246-1250.
  • 5刘剑荣,张勇,陈玲.小儿肺炎1224例肺炎支原体抗体检测结果分析[J].临床和实验医学杂志,2010,9(1):54-55. 被引量:23
  • 6李芳君,杨军,陈志刚.儿童肺炎支原体肺炎免疫功能检测结果分析[J].临床儿科杂志,2004,22(4):211-211. 被引量:19
  • 7Stemach I,Podisadlowicz Borzecka M,Grzolenski T,et al.Humorl and cellular immunity in children wity Mycoplasma pneumoniae infection:a 12 year prospective study [J].Clin Diagn Lab Tmmunol,2012,12(10):1246-1250.
  • 8宁怀军.肺炎支原体肺炎导致免疫力低下的临床观察[J].医学文选,2003,22(6):889-889. 被引量:8
  • 9Hou AC,Lu Y,Sha L,et al.T(HI) and T(H2) cells in children with mycoplasma pneumonia [J].Zhonghua Er Ke Za Zhi,2013,41(9):652-656.
  • 10Cimolai N.Corticosteroids and complicated M ycoplasma Pneumoniae infection[J].Pediatr PuImonol,2011,41(10):1008-1009.

二级参考文献30

  • 1李兴矗,殷敏,梁志强.某地区肺炎患儿肺炎支原体感染血清流行病学调查[J].济宁医学院学报,2004,27(2):66-67. 被引量:14
  • 2崔振泽,赵淑琴,蔡栩栩,李晓辉.肺炎支原体肺炎的发病机制[J].实用儿科临床杂志,1996,11(1):46-46. 被引量:28
  • 3张代民,俞万泉,许会彬,王小军,赵炜,刘慧.1824例小儿肺炎支原体抗体检测报告[J].实用医药杂志,2006,23(9):1097-1099. 被引量:23
  • 4Morozumi M,Ito A,Murayama SY,et al.Assessment of realtime PCR for diagnosis Mycoplasma pneumoniae pneumonia in pediatric patients[J].Can J Microbiol,2006,52(2):125-126.
  • 5Waties KB,Talkington DF.Mycoplasma pneumoniae and its role as a human pathogen[J].Clin Microbiol Rev,2004,17(4):697-728.
  • 6胡亚美 江载芳.诸福棠实用儿科学[M]:第7版[M].北京:人民卫生出版社,2002.1290-1294.
  • 7叶任高.内科学[J]北京:人民卫生出版社,2000.
  • 8Loens K, Goossens H, Ieven M. Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods [ J ] . Eur J Clin Microbiol Infect Dis, 2010, 29 (9) : 1055 - 1069.
  • 9Narita M. Pathogenesis of extrapulmonary manifestations of My- coplasma pneumoniae infection with special reference to pneu- monia [J]. Journal of infection and chemotherapy, 2010, 16 (3): 162-169.
  • 10Oishi T, Narita M, Matsui K, et al. Clinical implications of interleukin - 18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia [J]. Journal of Infection and Chem- otherapy, 2011, 17 (6): 803-806.

共引文献235

同被引文献178

  • 1胡亚美,江载芳.诸福棠实用儿科学[M].7版人民卫生出版社,2002:1204-1205.
  • 2胡亚美 江载芳.实用儿科学[M].北京:人民卫生出版社,2002.2520-2521.
  • 3董宗祈.肺炎支原体感染的致病机制与治疗的关系[J].实用儿科临床杂志,2007,22(4):243-245. 被引量:228
  • 4陈敏.小儿支原体肺炎的免疫功能检测及分析[J].医学临床研究,2007,24(11):1907-1908. 被引量:3
  • 5冯梅,王一彪,孙若鹏.先天性心脏病患儿辅助性T细胞亚群TH1、TH2及红细胞免疫功能的研究[J].中华儿科杂志,2007,45(12):947-948. 被引量:12
  • 6Youn Y S,Lee S C,Rhim J W,et al.Early additional immune-modulators for mycoplasma pneumoniae pneumonia in children:an observation study[J].Infect Chemother,2014,46(4):239.
  • 7Ye Q,Xu X J,Shao W X,et al.Mycoplasma pneumoniae infection in children is a risk factor for developing allergic diseases[J].Scientific World Journal,2014,2014:986527.
  • 8Meyer Sauteur P M,Jacobs B C,Spuesens E B,et al.Antibody responses to mycoplasma pneumoniae:role in pathogenesis and diagnosis of encephalitis[J].PLo S Pathog,2014,10(6):e1003983.
  • 9Izumikawa K,Izumikawa K,Takazono T,et al.Clinical features,risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia:a review of the Japanese literature[J].J Infect Chemother,2014,20(3):181.
  • 10MARRIE T J,COSTAIN N,LASCOLA B,et al.The role of atypical pathogens in community-acquired pneumonia[J].Semin Respir Crit Care Med,2012,33(3):244-256.

引证文献23

二级引证文献249

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部